SPC184
Etelkalsetíð eða salt þar af, að meðtöldu etelkalsetíðhýdróklóríði
Status:
VeittApplication date:
7.3.2017Application published:
15.4.2017Grant published:
15.5.2019
Max expiry date:
14.11.2031Medicine name:
ParsabivMedicine for children:
No
Timeline
Today
7.3.2017Application
15.4.2017Publication
15.5.2019Registration
14.11.2031Expires
Marketing license
IS authorization number:
EU/1/16/1142/001-004; EU/1/16/1142/005-008; EU/1/16/1142/009-012Date:
1.12.2016
Foreign authorization number:
EU/1/16/1142Date:
11.11.2016
Owner
Name:
Kai Pharmaceuticals, Inc.Address:
270 Littlefield Avenue, South San Francisco US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2459208